niryuu/sni-each-converted huggingface dataset:
The patient was brought to an intensive care unit 10 hours after intake of 1200 mg mirtazapine and 20 mg lorazepam and laying outside at outdoor temperatures below 0 degree C.
Output: non-adverse drug event
The process healed after surgical treatment and chemotherapy for 1 year.
Output: non-adverse drug event
The crucial factors contributing to the deterioration of both patients in the two cases presented were the concentration of phenytoin manually infused and the possibility that their high-risk status made them poor candidates for manual intravenous phenytoin.
Output: non-adverse drug event
Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia.
Output: non-adverse drug event
Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis.
Output: non-adverse drug event
Recently, UFT has been extensively studied for colorectal, pancreatic, and various types of cancer in North America and Europe, especially with leukovorin.
Output: non-adverse drug event
A second challenge while the patient received all fluids and electrolytes intravenously again resulted in decreased serum sodium concentration (134 to 126 mEq/L) after urinary loss of only 69 mEq of cation.
Output: non-adverse drug event
Abemayor).
Output: non-adverse drug event
Both authors discuss a method of creating a postauricular pocket, burying the ear pedicle, and using costal cartilage for an inlay helical graft.
Output: non-adverse drug event
The other ten were given Adriamycin without this compression.
Output: non-adverse drug event
It appears that this secondary malignancy was due to his prolonged chemotherapy.
Output: non-adverse drug event
Intrathecal application of chemotherapeutics has been the mainstay of central nervous system prophylaxis in acute lymphoblastic leukemia treatment.
Output: non-adverse drug event
Introduction of the balloon into the left atrium resulted in thrombotic occlusion of the mitral valve.
Output: non-adverse drug event
The development of nephrotic-range proteinuria after renal transplantation is an unfavourable prognostic factor for graft survival.
Output: non-adverse drug event
Due to the costs and risks of standard therapy, we decided to manage the patient supportively.
Output: non-adverse drug event
Adenomyosis in the broad ligament and tamoxifen: report of a case.
Output: non-adverse drug event
Three of the four patients also had bilateral ptosis.
Output: non-adverse drug event
Daptomycin is a lipopeptide antibiotic active against multidrug-resistant gram-positive organisms.
Output: non-adverse drug event
The corneal ulcer progressed despite aggressive antifungal treatment, requiring amputation of the corneal flap and daily debridement.
Output: non-adverse drug event
We report a case of DCL that developed in the context of the immune reconstitution inflammatory syndrome (IRIS) in a man with AIDS following initiation of antiretroviral therapy.
Output: non-adverse drug event
There was no evidence of recurrent myeloma after the initial remission on cyclophosphamide therapy.
Output: non-adverse drug event
So this potential drug-drug interaction could be investigated, the patient stopped taking both drugs for 1 week.
Output: non-adverse drug event
Specifically, for children with a family history of gallbladder, biliary tract, liver or pancreas dysfunction, ceftriaxone may not be the drug of choice since the likelihood of complications is increased in this population.
Output: non-adverse drug event
A 13-year-old girl with acute lymphocytic leukemia was treated according to the protocol of the BFM Group (BFM-95, HRG).
Output: non-adverse drug event
She received several vasoactive infusions during her admission, including nesiritide.
Output: non-adverse drug event
Histologic evaluation showed massive panlobular necrosis.
Output: non-adverse drug event
Antitumor activity was observed in four patients.
Output: non-adverse drug event
Another explanation for the decreased drug levels might be an increased volume of distribution.
Output: non-adverse drug event
This paralleled the rise in the number of children with tuberculous infection and disease seen at our institution, from an average 96 per year to 213 per year during these two time periods.
Output: non-adverse drug event
Trying to adjust the treatment to the patient's requirements, Carbamazepine together with Oxybutynin and Dantrolene was readministrated in lower doses.
Output: non-adverse drug event
Domestic dogs and cats may be another reservoir.
Output: non-adverse drug event
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
Output: non-adverse drug event
Evidence-based mental health use of anticonvulsants during pregnancy.
Output: non-adverse drug event
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Output: non-adverse drug event
Pulmonary GVHD and pulmonary aspergillosis were also observed.
Output: non-adverse drug event
The patient had a favourable outcome.
Output: non-adverse drug event
Coincident with the preeclampsia was a postdural puncture headache complicating the diagnosis of late postpartum preeclampsia.
Output: non-adverse drug event
We discuss the limitations of conventional drug therapy and the lack of a sustained response to plasmapheresis.
Output: non-adverse drug event
Early postsplenectomy arthritis caused by penicillin-resistant Streptococcus pneumoniae.
Output: non-adverse drug event
Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia.
Output: non-adverse drug event
One week later, the patient was again extubated and 3 days later was transferred to a peripheral ward.
Output: non-adverse drug event
Three children completely recovered; one patient relapsed and died.
Output: non-adverse drug event
The patient was successfully managed with clopidogrel therapy during the 16 months follow-up without recurrent thrombotic or hemorrhagic events.
Output: non-adverse drug event
Bilateral inguinal scrofuloderma during steroid therapy in a patient with bullous pemphigoid.
Output: non-adverse drug event
This is the first report on the use of charcoal haemoperfusion for acute poisoning in Australia.
Output: non-adverse drug event
Lack of experience with patient reporting in real life was one of the main drawbacks in this debate.
Output: non-adverse drug event
Successful treatment with partial resection of the posterior mitral valve leaflet and antibiotic therapy with cefazolin.
Output: non-adverse drug event
Patient 1 developed squamous cell carcinoma of the skin with recurrence, and Patient 2 developed anaplastic carcinoma of the urinary bladder.
Output: non-adverse drug event
RESULTS: Withdrawal of oral colchicine therapy was followed by rapid corneal wound healing in both patients.
Output: non-adverse drug event
Thus, olanzapine dose reduction may permit treatment continuation where this is clinically indicated.
Output: non-adverse drug event
Action of intracoronary nitroglycerin in refractory coronary artery spasm.
Output: non-adverse drug event
Despite reduction in immunosuppression, 30%-40% of recipients progress to allograft loss.
Output: non-adverse drug event
In more than 6,000 patient applications of rapid atrial pacing, there has been only one failure to convert the tachycardia.
Output: non-adverse drug event
Reversal of neuroleptic-induced stupor by procyclidin.
Output: non-adverse drug event
Seven days later, she had full-blown, severe hepatitis.
Output: non-adverse drug event
Therefore, contact lens wear should be discontinued to prevent further complications.
Output: non-adverse drug event
Milk:plasma ratios were less than 1, although a higher ratio would be predicted.
Output: non-adverse drug event
She developed a pre-engraftment immune reaction, which responded well to prednisolone, and engraftment was documented.
Output: non-adverse drug event
This effect of cisapride is presumably related to its serotonin3 antagonistic property.
Output: non-adverse drug event
We report here the case of a 36-year-old man with pre-B cell acute lymphoblastic leukemia.
Output: non-adverse drug event
Seven cases of successfully treated Candida albicans cerebrospinal fluid shunt infections are reported.
Output: non-adverse drug event
Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic agents.
Output: non-adverse drug event
Pathologic findings demonstrated on MR were (1) chronic brain edema, demonstrable over a period of 3-14 months (proved by autopsy in one patient); (2) multifocal white matter necrosis; and (3) deep brain atrophy.
Output: non-adverse drug event
The patient's blurred vision gradually improved, but visual field defect remained.
Output: non-adverse drug event
A reduction of up to 33 percent in pituitary tumor size has been reported in more than half of the 27 cases studied from four groups.
Output: non-adverse drug event
The patient eventually had full resolution of her symptoms.
Output: non-adverse drug event
Discontinuing the oxybutynin leads to complete neurological recovery associated with normalisation of her blood pressure.
Output: non-adverse drug event
The recognition of the characteristic features of the syndrome is vital since early aggressive therapy is indicated.
Output: non-adverse drug event
It was characterized by hyperandrogenism and polycystic ovaries in all cases, and it was associated with weight gain and menstrual disorders in 2 of the 3 women.
Output: non-adverse drug event
The four other North American cases are reviewed, and the epidemiology of the infection in animals is discussed.
Output: non-adverse drug event
Two days after surgery, signs of orbital cellulitis developed in his right orbit.
Output: non-adverse drug event
Physiologic data were analyzed with an analysis of variance, with the Kruskal-Wallis test used for nonparametric data.
Output: non-adverse drug event
Cefoxitin should either be used with great caution or not prescribed in combination with aminoglycoside antibiotics.
Output: non-adverse drug event
We found TPO and platelet responses to be generally antagonistic through all cycles.
Output: non-adverse drug event
Therefore, we believe that screening for HBsAg is insufficient for detecting latent HBV carriers, and that investigation for hepatitis B core antibody (HBcAb) is essential.
Output: non-adverse drug event
METHODS: Small case series.
Output: non-adverse drug event
The allergological work-up was negative, except for intradermal test with gelatine.
Output: non-adverse drug event
Laboratory investigations confirmed a metabolic acidosis (pH 7.15) and hyperchloremia.
Output: non-adverse drug event
Churg-Strauss syndrome, or allergic granulomatous angiitis, is an uncommon vasculitic syndrome.
Output: non-adverse drug event
Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids.
Output: non-adverse drug event
Full recovery to pre-episode status of a quiet eye with clear vitreous was seen in all patients.
Output: non-adverse drug event
Post-steroid septic arthritis can be treated with irrigation pump assisted arthroscopic synovectomy.
Output: non-adverse drug event
Incidence of myopathy in patients treated with antimalarials.
Output: non-adverse drug event
We report a 51-year-old male with adult T cell leukemia (ATL) who received a BMT from an HLA-identical unrelated donor.
Output: non-adverse drug event
Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy.
Output: non-adverse drug event
This may be due to a change in the type of metabolites excreted.
Output: non-adverse drug event
Platelet count less than SHARP: what does a case series reveal?
Output: non-adverse drug event
CASE SUMMARY: A 77-year-old white woman presented to the hospital with elevated serum creatinine, oliguria for the past 24 hours, arthralgia, fatigue, fever, and bilateral flank pain.
Output: non-adverse drug event
The pathogenesis of the liver changes and their possible relationship to splenomegaly and busulphan toxicity are considered.
Output: non-adverse drug event
Early data identifies atomoxetine's influence on Tourette symptomatology to be not merely equivocal but potentially suppressive in the manifestation of tics.
Output: non-adverse drug event
Serious lead poisoning in childhood: still a problem after a century.
Output: non-adverse drug event
Approximately 5-6% of intravaginal clindamycin is absorbed in the bloodstream, making systemic effects possible.
Output: non-adverse drug event
Intravenous injection of diazepam caused a rapid normalization of the EEG with disappearance of the clinical manifestations.
Output: non-adverse drug event
METHODS: The patient was a 20-year-old woman.
Output: non-adverse drug event
In addition, 1 of these biopsy specimens also had scattered single eosinophils, unlike autoimmune hepatitis.
Output: non-adverse drug event
Antibodies for HIT by enzyme-linked immunosorbent assay were positive.
Output: non-adverse drug event
RESULTS: A total of 178 cases were identified.
Output: non-adverse drug event
A kidney transplantation recipient 1983 to 1995, she was diagnosed with Charcot-Marie Tooth disease in 1991.
Output: non-adverse drug event
METHODS: Case series consisting of 3 patients treated with rifabutin were retrospectively studied.
Output: non-adverse drug event
Pulses have been given for periods up to three years without evident toxicity.
Output: non-adverse drug event
Despite this improvement, the patient became resistant to the clozapine titration schedule due to complaints of sedation.
Output: non-adverse drug event
METHOD: The case histories of three geriatric patients treated with fluoxetine for depression or obsessive compulsive disorder are presented.
Output: non-adverse drug event
In most of these studies, the effect of acarbose (on reactive hypoglycemia) was evaluated over several hours postprandially or after oral glucose load.
Output: non-adverse drug event
Methicillin-resistant Staphylococcus aureus osteomyelitis of the scaphoid from a catheter in the radial artery.
Output: non-adverse drug event
Neuroleptic malignant syndrome and lithium carbonate.
Output: non-adverse drug event
CONCLUSIONS: Confocal microscopy can be a useful, noninvasive imaging technique helpful in the study, diagnosis, and treatment of Acanthamoeba keratitis.
Output: non-adverse drug event
All the alternative medications for rheumatological patients are significantly more toxic than HCQ.
Output: non-adverse drug event
There are very few reports about asterixis as a side effect of treatment with psychopharmacologic agents.
Output: non-adverse drug event
The posterior hyaloid became taut and partially detached after the third injection and was almost completely detached 1 year later.
Output: non-adverse drug event
Successful treatment with dantrolene does not, however, preclude a recurrence of MH, and thus subsequent doses of dantrolene should be given.
Output: non-adverse drug event
Mitral valve prolapse and thromboembolic disease in pregnancy: a case report.
Output: non-adverse drug event
Successful treatment of molluscum contagiosum in the immunosuppressed adult with topical injection of streptococcal preparation OK-432.
Output: non-adverse drug event
There was no recurrence the following year.
Output: non-adverse drug event
In each case, brief periods (5 to 20 seconds) of rapid atrial pacing were effective in terminating the supraventricular tachycardia and resulted in a return to normal sinus rhythm.
Output: non-adverse drug event
CASE: A 71-year-old man without immunodeficiency developed corneal endotheliitis in the right eye.
Output: non-adverse drug event
Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Output: non-adverse drug event
Panic attacks occurred for the first time in a patient suffering from delusional depression during treatment with a combination of an antidepressant and a neuroleptic.
Output: non-adverse drug event
INVESTIGATIONS: Physical examination, blood and urine analyses, kidney biopsy and tonicity balance.
Output: non-adverse drug event
The purpose of this article was to provide a detailed review of the role of TNF-alpha in controlling hepatitis B viral infection and the clinical impact blockade might have on viral control.
Output: non-adverse drug event
CASE REPORT: A 64-year-old man was evaluated for chronic low-back pain after multiple spine surgeries.
Output: non-adverse drug event
The skin lesions disappeared almost completely within three months.
Output: non-adverse drug event
These agents have potent cytotoxic and immunomodulatory effects and are useful in the treatment of a variety of conditions, including inflammatory bowel disease.
Output: non-adverse drug event
We observed a 7.0% prevalence of QT, prolongation among all patients screened.
Output: non-adverse drug event
Hematologic evaluation disclosed pancytopenia: red blood cells 283 x 10(4)/mm3; white blood cells 700/mm3; and platelets 8000/mm3.
Output: non-adverse drug event
On discontinuation of the drug, serum CK concentrations returned to normal within eight days.
Output: non-adverse drug event
The etiopathogenesis and management of this condition are presented.
Output: non-adverse drug event
We describe a 49-year-old woman who presented in 2002 with pure red cell aplasia (PRCA), systemic lupus erythematosus (SLE), and idiopathic portal hypertension (IPH) that developed following a thymectomy.
Output: non-adverse drug event
Formation of these plugs was probably due to extensive tumor necrosis at the level of the walls of the major uterine veins, which resulted in an open exchange of tumor plugs to the vascular spaces; decrease in tumor tissue coherence secondary to chemotherapy may have further contributed to the formation of tumor emboli.
Output: non-adverse drug event
Improved awareness and rapid treatment of the second patient had a favorable outcome with no sequelae.
Output: non-adverse drug event
The patient responded promptly to appropriate antibiotics.
Output: non-adverse drug event
In clinical practice, serum level monitoring of anticonvulsant drugs is usually adequate.
Output: non-adverse drug event
Medical management of the head and neck cancer patient (HNCP) most often will include radiation therapy to the head and neck region.
Output: non-adverse drug event
Further research and better communication among health care professionals are needed to determine if prophylaxis can reduce adverse ocular events.
Output: non-adverse drug event
However, brain metastasis was diagnosed.
Output: non-adverse drug event
One was alive with no evidence of disease at 14 month follow-up, while 2 had residual disease after bone marrow transplantation and died of complications at 4 and 5 months after transplantation.
Output: non-adverse drug event
Blood transfusions worsen the evolution of this peculiar form of HUS.
Output: non-adverse drug event
NMS must be considered as part of the differential diagnosis of fever in burn patients receiving medication known to cause the syndrome.
Output: non-adverse drug event
They were both treated for stage IV neuroblastoma with chemotherapy, bone marrow transplant (BMT) conditioning that included total body irradiation and RA therapy after BMT, although the patient in case 1 had established renal insufficiency prior to the commencement of RA.
Output: non-adverse drug event
No re-occurrence of pancreatitis was observed in a 16 month follow-up.
Output: non-adverse drug event
Tests for antimyeloperoxidase ANCA were repeatedly negative before the drug was started, strongly implicating the drug as the cause of the episode.
Output: non-adverse drug event
Acute cervico-facial oedema and loss of consciousness following ingestion of barracuda fish.
Output: non-adverse drug event
Crohn's disease has not been associated with its administration.
Output: non-adverse drug event
Digoxin serum levels and toxicity risks increase with the addition of amiodarone.
Output: non-adverse drug event
Accordingly, a practical and safe approach to MAOI dietary restrictions remains an essential component of patient management.
Output: non-adverse drug event
Along with normal results of a hepatorenal panel and normal serum vitamin B12 and folate levels, no metabolic or endocrinologic alterations were present to explain the nail pigmentation and dystrophic changes.
Output: non-adverse drug event
The patient recovered without sequelae with conservative therapy.
Output: non-adverse drug event
In a fifth case a 14-year-old boy developed papilloedema after taking a short course of tetracycline for bronchitis.
Output: non-adverse drug event
Reinstitution of intravenous anticholinergic medication provided relatively prompt relief.
Output: non-adverse drug event
Hematochezia subsided with conservative treatment after a discontinuance of Kalimate administration.
Output: non-adverse drug event
A spinal haematoma occurring in the subarachnoid as well as in the subdural space in a patient treated with anticoagulants.
Output: non-adverse drug event
Propranolol had to be given for eight months after surgery.
Output: non-adverse drug event
He developed rhabdomyolysis with hemoglobinuria after 2 weeks of treatment.
Output: non-adverse drug event
The additional finding of extensive resorption of the outer cortical surface and bone formation at the inner surface suggested a reversible phase after discontinuation of treatment.
Output: non-adverse drug event
The patient developed unusually severe hematological toxicity to chemotherapy as compared to nonsmall cell lung cancer patients without the GD defect.
Output: non-adverse drug event
The five human eyes of three patients have shown no evidence of intraocular toxicity with a median follow-up time of 3.6 months (range 2.0-6.4 months).
Output: non-adverse drug event
Patients who develop these reactions whilst receiving GSTM can be successfully changed to aurothioglucose.
Output: non-adverse drug event
Furthermore, pleiotropic effects of ACE inhibitors are unlikely to provide significant benefits in the absence of blood pressure reduction.
Output: non-adverse drug event
It is used alone or in combination with other lipid-lowering agents in the treatment of various forms of hypercholesterolemia.
Output: non-adverse drug event
An increasing range of drugs have been reported to cause sAML, including the alkylating agents, the epipodophyllotoxins and the anthracyclines, both as single agents and in combination (Pedersen-Bjergaard & Philip, 1991; Pedersen-Bjergaard & Rowley, 1994).
Output: non-adverse drug event
A skin biopsy specimen revealed microscopic, sterile, neutrophilic abscesses.
Output: non-adverse drug event
HNCPs with malignant disease require judicious dental treatment planning prior to radiation therapy (RT) and/or chemotherapy.
Output: non-adverse drug event
The child died 62 days after discontinuation of prostaglandin treatment.
Output: non-adverse drug event
Parkinsonian features were progressive, even after the patients had stopped work.
Output: non-adverse drug event
Adenomyosis confined to the broad ligament is extremely rare.
Output: non-adverse drug event
The most progressive neurological deficits like severe tetraspastic paresis, were seen only in the nondialytic renal insufficient group (3 patients), while the others had a more benign course of the disease.
Output: non-adverse drug event
Clinical recovery required an average of 42 days and was complete in four of five patients.
Output: non-adverse drug event
Another enzyme catalyzing the metabolism of antidepressants is the polymorphic S-mephenytoin hydroxylase.
Output: non-adverse drug event
In this report and other reports describing successful resuscitation, the total dose of sodium bicarbonate is conspicuously higher than in reports describing extracorporeal interventions.
Output: non-adverse drug event
Trichosporonosis appears to be an emerging fungal infection among immunocompromised individuals (including both hematological and solid organ transplant recipients).
Output: non-adverse drug event
Both the psoriasis and the HCL cleared.
Output: non-adverse drug event
He was hyperthermic (oral temperature 40.6 degrees C), diaphoretic, tachycardic (heart rate 140 beats/min), and tachypneic (respiratory rate 22 breaths/min), with severe muscle rigidity and shaking tremors.
Output: non-adverse drug event
Previously reported cases are reviewed.
Output: non-adverse drug event
He was taken to the emergency department and given intravenous methylprednisolone sodium succinate and intravenous diphenhydramine hydrochloride.
Output: non-adverse drug event
Neuroimaging shows bilateral subcortical and cortical edema with prominent posterior distribution.
Output: non-adverse drug event
All patients experienced severe anaemia after induction chemotherapy despite erythropoietin.
Output: non-adverse drug event
Both patients underwent successful thrombolysis after super-selective angiograms.
Output: non-adverse drug event
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.
Output: non-adverse drug event
In 2 cats, rebound hyperglycemia was diagnosed on routine serial blood glucose determinations.
Output: non-adverse drug event
Post-transplant lymphoproliferative disorder (PTLD) in the central nervous system (CNS) has a poor prognosis.
Output: non-adverse drug event
Isoniazid and vitamin B6 were co-administered with adalimumab.
Output: non-adverse drug event
This case report represents the successful usage of LS for weaning from cardiopulmonary bypass circulation after coronary artery bypass surgery.
Output: non-adverse drug event
OBJECTIVE: We describe the prolonged clinical benefit of murine chimeric antitumor necrosis factor (TNF)-alpha monoclonal antibody, infliximab, on pediatric patients with Crohn's disease and ileal pouch anal anastomosis (IPAA).
Output: non-adverse drug event
We describe the development of severe lipoatrophy in a patient treated with biphasic aspart.
Output: non-adverse drug event
Although preemptive therapy with ganciclovir prevented successfully severe CMV diseases and CMV-related mortality, a patient developed persistent positive CMV antigenemia for more than 1 year after transplantation and CMV disease, despite the use of ganciclovir and foscarnet.
Output: non-adverse drug event
A 59-year-old female was admitted to Tsukuba University Hospital and diagnosed as IgA-lambda multiple myeloma (stage IIIA).
Output: non-adverse drug event
Severely elevated serum lithium levels were found.
Output: non-adverse drug event
Pseudomonas spp. are of increasing importance in human immunodeficiency virus-infected children causing significant morbidity and increased hospitalization.
Output: non-adverse drug event
Colonoscopy revealed a Dukes Stage B colonic adenocarcinoma.
Output: non-adverse drug event
Acute chest pain is a common presentation in emergency.
Output: non-adverse drug event
The mechanism behind this observation may be similar to that of previously reported protease inhibitor-associated fat redistribution, but instead involving the adipose tissue of discrete uncommon benign tumors.
Output: non-adverse drug event
In contrast, newer North American guidelines have focused on the severity of illness of community-acquired pneumonia.
Output: non-adverse drug event
At explant, all four systems had clots adherent to the surface of the tubing and connectors on the pump outflow side of the circuit.
Output: non-adverse drug event
Unusual side-effects due to clobazam: a case report with genetic study of CYP2C19.
Output: non-adverse drug event
Two days prior to admission, metoclopramide 10 mg orally three times per day was started for a gastrointestinal condition.
Output: non-adverse drug event
In both patients therapy with high dose acyclovir, 10 mg/kg q8h, intravenously, was instituted based on clinical presentation.
Output: non-adverse drug event
OBJECTIVE: To discuss the various diagnostic and treatment options that should be considered when managing parotid duct injuries that result from skin cancer extirpation.
Output: non-adverse drug event
Nausea, vomiting and acute pancreatitis were also observed in one patient.
Output: non-adverse drug event
The combination therapy of interferon alpha and ribavirin was given to a 50-year-old female with CHC who had not responded to a previous treatment by interferon alpha.
Output: non-adverse drug event
INTERVENTIONS: Treatment with aspirin and prednisone in one patient.
Output: non-adverse drug event
The reaction subsided after treatment with diphenhydramine and dexamethasone.
Output: non-adverse drug event
These observations add to the literature on pro-arrhythmic effects of commonly used antiarrhythmic drugs.
Output: non-adverse drug event
Three such patients are described whose main features were uncontrolled seizures, progressive dementia, behaviour disorder, muscular pseudohypertrophy, and a relative paucity of localizing neurological signs or signs of raised intracranial pressure.
Output: non-adverse drug event
Three patients (APML = 1 and ALL = 2) are still alive and disease-free.
Output: non-adverse drug event
We describe a patient in whom this was the primary manifestation of drug hypersensitivity.
Output: non-adverse drug event
We therefore strongly argue in favor of extended screening recommendations for infectious diseases including viral infections before considering a therapy with infliximab.
Output: non-adverse drug event
All patients improved rapidly after discontinuation of 5-ASA compounds.
Output: non-adverse drug event
Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions.
Output: non-adverse drug event
OBJECTIVE: The aim of this study was to evaluate the present status of surviving patients 10 years later, together with the latest clinical and histological data on patients who had died.
Output: non-adverse drug event
At postmortem examination, the characteristic microvascular lesions of the hemolytic-uremic syndrome were found in the kidneys.
Output: non-adverse drug event
Single and multiple verrucous plantaris lesions are well known for their resistance to conservative methods of treatment.
Output: non-adverse drug event
Its treatment is mainly based upon discontinuation of heparin therapy.
Output: non-adverse drug event
Development of malignant breast microcalcifications after neoadjuvant chemotherapy in advanced breast cancer.
Output: non-adverse drug event
We report a case of graft versus host disease after liver transplantation in which the diagnosis was made by short tandem repeat analysis.
Output: non-adverse drug event
Copperhead envenomations in the Carolinas.
Output: non-adverse drug event
Severe hypertension in newborn after pyeloplasty of hydronephrotic kidney.
Output: non-adverse drug event
CASE DESCRIPTION: A 24-year-old 732-kg (1,610-lb) pregnant Belgian draft horse mare developed neuropathy and signs of intractable pain following colic surgery.
Output: non-adverse drug event
TEN is a disease of both children and adults, but TEN in early infancy is a rare event; only two well-documented cases in infants less than 6 months of age have been reported.
Output: non-adverse drug event
Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.
Output: non-adverse drug event
Recently there have been concerns relating to liver and now kidney toxicity.
Output: non-adverse drug event
CASE REPORT: We present cases of 10 patients with Type 2 diabetes mellitus who developed acute renal failure and severe lactic acidosis.
Output: non-adverse drug event
Findings from biopsy specimens of skin and jejunum suggested a cell-mediated pathogenesis, and lymphoproliferative studies of the patient's mononuclear cells revealed a positive response to phenobarbital.
Output: non-adverse drug event
CONCLUSIONS: JHR should be an anticipated reaction to early doses of antibiotic treatment for treponemal diseases, such as syphilis.
Output: non-adverse drug event
She was transfused with four (4) units of packed cells and Zidovudine was replaced with Stavudine.
Output: non-adverse drug event
Electromyography, muscle biopsy, and the course of the patient's illness were consistent with polymyositis.
Output: non-adverse drug event
The development of a rifampin-impregnated silicone catheter yielded excellent results in infection prevention and treatment in vitro as well as in an animal model.
Output: non-adverse drug event
We review the medical literature about mucormycosis peritonitis which, albeit rare, carries very high mortality.
Output: non-adverse drug event
Complete regression of the CIN was observable after 60 days of therapy.
Output: non-adverse drug event
Rush oral desensitization with Viokase solution was attempted, starting with 5 mg, and the dose was doubled every 20 minutes, aiming to reach a cumulative dose of 700 mg.
Output: non-adverse drug event
The infiltrate was treated with a combination of topical polyhexamethylene biguanide, chlorhexidine, atropine sulfate, and oral itraconazole and resolved within 2 months.
Output: non-adverse drug event
A 67-year-old man on long-term carbamazepine therapy underwent elective coronary artery bypass grafting.
Output: non-adverse drug event
A 55- year-old man had been followed for chronic hepatitis B infection for 10 years at another institution.
Output: non-adverse drug event
The first was a 56-year-old male treated with multiple chemotherapeutics for multiple myeloma.
Output: non-adverse drug event
Beneficial late administration of obidoxime in malathion poisoning.
Output: non-adverse drug event
These areas were subject to repeated exposure to solvents.
Output: non-adverse drug event
Initially, she responded well to corticosteroids, but relapsed when medication was discontinued.
Output: non-adverse drug event
We describe a preterm infant with severe idiopathic respiratory distress syndrome (iRDS, hyaline membrane disease) who needed artificial ventilation with high inspiratory pressure, high frequencies, 100% oxygen and developed a symptomatic patent ductus arteriosus (sPDA) in the course of the disease.
Output: non-adverse drug event
It is important that nurses understand potential side effects of these agents, know of possible interventions, and participate in research to identify effective interventions.
Output: non-adverse drug event
The patient was also found to have Hashimoto's thyroiditis.
Output: non-adverse drug event
Neither a complication nor clinical or radiological sequelae occurred in this patient.
Output: non-adverse drug event
Twenty-four to seventy-two hours following the switch, all patients developed intractable headache, despite the use of different symptomatic drugs.
Output: non-adverse drug event
It has also been seen in people with gastrointestinal diseases with malabsorption.
Output: non-adverse drug event
The clinical course of a 9-year-old diagnosed with attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and Tourette's disorder and treated with a combination of methylphenidate, clonidine, and fluoxetine is described.
Output: non-adverse drug event
Power spectrum analysis studies revealed that heart rate had significantly improved and that power spectrum cardiovascular parameters had returned to normal.
Output: non-adverse drug event
The authors report a world class runner who sustained a rupture requiring surgical intervention.
Output: non-adverse drug event
Aromatic antiepileptic agents, such as phenytoin, carbamazepine, and phenobarbital are the most frequent causes of this syndrome.
Output: non-adverse drug event
Radiologic findings were consistent with PI.
Output: non-adverse drug event
A periodic examination of the nasal septum should be undertaken in patients with ABPA and rhinitis on long term inhaled oral and intranasal corticosteroids along with oral corticosteroids.
Output: non-adverse drug event
We present a case of accidental injection of tranexamic acid instead of bupivacaine during spinal anesthesia.
Output: non-adverse drug event
Patients experienced a mean reduction of 92% (a mean drop in frequency of 21.7 to 1.7 episodes per week).
Output: non-adverse drug event
TB should always be considered as a possible diagnosis when treating febrile immunocompromised patients.
Output: non-adverse drug event
Asthmatic medications can place the patient at risk of dental erosion by reducing salivary protection against extrinsic or intrinsic acids.
Output: non-adverse drug event
The duration of the pauses were equal or almost equal to one short plus one long P-P interval or to twice the basic sinus cycle.
Output: non-adverse drug event
Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function.
Output: non-adverse drug event
Over the next 15 h she developed progressive hemolysis and methemoglobinemia.
Output: non-adverse drug event
She subsequently developed a classic varicella rash, sever back pain, rapidly progressive hepatic failure, pneumonitis, and encephalopathy.
Output: non-adverse drug event
Due to the difficulty in identifying and verifying exposures to such agents, only a few chemical compounds are clearly linked to malignancies.
Output: non-adverse drug event
He had experienced subarachnoid hemorrhage (SAH) from a left vertebral dissecting aneurysm, and had subsequently received a ventriculoperitoneal shunt against post-SAH hydrocephalus.
Output: non-adverse drug event
Different reasons for the RPE atrophy such as collateral damage of the choriocapillaris with a subsequent secondary RPE atrophy, a direct photochemical effect due to the early localization of the photosensitizer in the RPE, or a depigmentation or photobleaching of the RPE, which led to a window defect in the fluorescein angiogram without loss of the major functional properties of the RPE, are possible mechanisms involved in the development of the documented lesion.
Output: non-adverse drug event
The kidney function returned to normal within 1 week.
Output: non-adverse drug event
Record et al. have recommended oral loading in selected patients.
Output: non-adverse drug event
Since continuation/maintenance ECT is not well established, prophylactic therapy in recurrent illnesses is more commonly carried out using antidepressive medication alone or more often in combination with lithium.
Output: non-adverse drug event
Furthermore, therapy with dantrolene has been demonstrated to be beneficial in the treatment of MH associated with diabetic coma.
Output: non-adverse drug event
CONCLUSIONS: Topical imiquimod 5% cream seems to be a useful treatment for eyelid nodular basal cell carcinoma in selected cases, but further long-term studies are needed to assess the efficacy and safety of this approach.
Output: non-adverse drug event
PURPOSE: To review the current literature on suspected green tea-related hepatic reactions and to describe two new cases reported within the framework of the Italian surveillance system of natural health products.
Output: non-adverse drug event
High-resolution CT (HRCT) findings of this disease were compared with the pathology.
Output: non-adverse drug event
Continuous subcutaneous infusion was well tolerated and about 80 per cent as effective as intravenous therapy in chelating iron.
Output: non-adverse drug event
Migraine prevention.
Output: non-adverse drug event
Cutaneous lesions resolved two weeks after the drug was withdrawn and topical steroid treatment was instituted.
Output: non-adverse drug event
Pure red cell aplasia (PRCA) is a rare complication after ABO-incompatible allogeneic stem cell transplantation, but its mechanism is still unknown.
Output: non-adverse drug event
It can also be used to treat hematuria through its action on decreasing urinary fibrinolysis.
Output: non-adverse drug event
OBJECTIVE: We identified a group of patients with rheumatoid arthritis (RA) who were sensitive to both the beneficial and the side effects of intramuscular (im) gold treatment and whose disease was well controlled with doses of gold between 2 mg every 6 weeks and 5 mg weekly.
Output: non-adverse drug event
Photo-onycholysis associated with drugs is an uncommon disorder.
Output: non-adverse drug event
Those side effects that occurred, predominantly iron deficiencies, hypertension, and hyperkalemia, were controlled by appropriate clinical management.
Output: non-adverse drug event
We followed these patients by A scan ultrasonographic ocular measurements, documenting reduction of the anterior chamber depth combined with lens thickening.
Output: non-adverse drug event
We present a patient who developed extensive Molluscum Contagiosum (MC) lesions shortly after being started on HAART.
Output: non-adverse drug event
In the case of foul drainage, burn reconstruction would be delayed.
Output: non-adverse drug event
This is not a controlled study but an anecdotal experience that resulted in improved outcomes in a patient with multiple allergies, including iron dextran.
Output: non-adverse drug event
All-trans retinoic acid has revolutionized the treatment of acute promyelocytic leukemia, but this therapy is often complicated by the all-trans retinoic acid syndrome.
Output: non-adverse drug event
We present a case of disseminated cryptococcal infection in a patient with pemphigus vulgaris treated with high dose corticosteroids as monotherapy.
Output: non-adverse drug event
Effectiveness of spray application of ACNU in the local control of malignant gliomas: report of two cases.
Output: non-adverse drug event
They represented a typical picture of NE: two of them died because of septic shock; five patients had subileus with irritation of the peritoneum; and one had hepatosplenic abscesses confirmed 6 months later by post-mortem examination.
Output: non-adverse drug event
Proposed mechanisms for leukemogenesis are presented.
Output: non-adverse drug event
Whether the drug is unmasking latent autoimmune hepatitis is unclear.
Output: non-adverse drug event
The patient was treated with intraventricular and intravenous vancomycin, intravenous teicoplanin and oral rifampicin, followed by oral chloramphenicol and rifampicin.
Output: non-adverse drug event
The timolol was discontinued, and the patient's heart rate increased.
Output: non-adverse drug event
Although the current metabolism of the 2 drugs in combination is poorly understood, the potential for serious interactions seems to exist in the rapidly growing population of persons with asthma, for whom they may be prescribed.
Output: non-adverse drug event
It is extremely resistant to standard treatment, and confers a poor prognosis for this disease.
Output: non-adverse drug event
Her medical history included vascular dementia accompanied by depression, arterial hypertension, and heart failure, as well as cardiac pacemaker implantation several years earlier for severe bradyarrythmia.
Output: non-adverse drug event
CONCLUSIONS: Photodynamic therapy for cholangiocarcinoma is safe and technically feasible with a preloaded biliary catheter and a monorail technique for catheter positioning.
Output: non-adverse drug event
There has been no further recurrence in the long-term follow-up.
Output: non-adverse drug event
Some hiccups are associated with certain diseases or occur postsurgically, and life-restricting intractable hiccups should be treated.
Output: non-adverse drug event
The patient was successfully treated by discontinuation of cyclosporine and mycophenolate mofetil, initiation of systemic amphotericin B, and aggressive surgical debridement.
Output: non-adverse drug event
It is severe enough to require discontinuation of therapy in 1-10 percent of patients.
Output: non-adverse drug event
The lesions resolved completely approximately 30 min after removal of the hands from water.
Output: non-adverse drug event
Here, we describe a case of Epstein-Barr virus-associated polymorphic PTLD that developed shortly after treatment for cytomegalovirus reactivation in a lung transplant recipient who was preoperatively seropositive for both cytomegalovirus and Epstein-Barr virus.
Output: non-adverse drug event
Our experience of this case led us to conclude that: patients with pulmonary metastases may develop bilateral and/or recurrent pneumothoraces following chemotherapy; computed tomography scan is essential for defining the cause of SSP; and closed chest tube drainage remains the therapy of choice, while chemical pleurodesis may also be used to prevent recidivant SSP.
Output: non-adverse drug event
MR appears to be valuable in the detection of abnormalities induced by treatment with high-dose methotrexate.
Output: non-adverse drug event
The primary goal is to identify and treat the underlying disorder, while minimizing the impact on hemoglobin (Hb) levels.
Output: non-adverse drug event
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Output: non-adverse drug event
Diffusion-weighted MRI (DWI) may help to distinguish between ischemic stroke and chemotherapy-related leukoencephalopathy.
Output: non-adverse drug event
Ischemic cholangitis caused by transcatheter hepatic arterial chemoembolization 10 months after resection of the extrahepatic bile duct.
Output: non-adverse drug event
DISCUSSION: Two patients with hypothyroidism had remained euthyroid and stable while receiving 1 levothyroxine product, but became symptomatic with dramatically increased serum TSH concentrations while receiving what were thought to be comparable dosages of another levothyroxine product.
Output: non-adverse drug event
Although weight gain often coincides with hyperglycemia in patients taking atypical antipsychotics, it does not seem to be a necessary causal factor.
Output: non-adverse drug event
Symptomatic cluster headache related to ocular pathologies have been rarely described.
Output: non-adverse drug event
Laboratory studies showed leukocyturia, thrombocytopenia, severe anemia, and tarry stools.
Output: non-adverse drug event
Classification included dry (7%), mild (48%), moderate (39%), and severe (6%).
Output: non-adverse drug event
PURPOSE: This paper reviews five newly diagnosed cases of DM type 1 in Israeli Air Force aviators that presented over the last 15 yr.
Output: non-adverse drug event
Treatment was given as direct observed therapy (DOT) and sputum cultures, blood chemistry and neurologic examination were undertaken on a regular basis.
Output: non-adverse drug event
The nocturia was defined as having more than two episodes of urination during sleep per night on average.
Output: non-adverse drug event
Because of her severe symptoms, mifepristone was administered for a period of 19 days.
Output: non-adverse drug event
Both the clinical picture of the patient as well as laboratory, imaging and histopathological findings may help in the diagnosis.
Output: non-adverse drug event
Another approach involves minimal debridement of the cartilage and letting the wound mature for 6 to 8 months.
Output: non-adverse drug event
RESULTS: A complete response (CR) was obtained for all three patients, resulting in a response rate of 100%.
Output: non-adverse drug event
Pigmentary aberrations are well known side effects of cytostatic chemotherapeutic agents.
Output: non-adverse drug event
At this writing, few cases of nondurally based intradural meningioma have been reported.
Output: non-adverse drug event
Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.
Output: non-adverse drug event
Patients at increased risk were those with severe disease and taking concomitant MTX and corticosteroids.
Output: non-adverse drug event
These organisms are, however, sensitive to vancomycin.
Output: non-adverse drug event
A 9-month-old boy with progressive hepatosplenomegaly and neurodevelopmental delay was studied.
Output: non-adverse drug event
MANAGEMENT: Thalidomide withdrawal, dexamethasone maintenance therapy, monthly oral courses of combined melphalan and prednisone, salvage therapy with bortezomib.
Output: non-adverse drug event
Symptoms mimicking Crohn's disease deteriorated under intensified immunosuppression and surgery.
Output: non-adverse drug event
In all cases SMS 201-995 treatment has been well tolerated and has few side-effects.
Output: non-adverse drug event
The use of such chemotherapy regimens in Ewing's tumours should be carefully considered, particularly when radiotherapy encompassing the spinal cord is an essential component of management.
Output: non-adverse drug event
Sudan IV staining indicated many lipid droplets in follicular cells.
Output: non-adverse drug event